| There
is a lot of research going on with regard to pemetrexed.
Use of pemetrexed in breast cancer
In vitro synergistic cytotoxicity of gemcitabine
and pemetrexed and pharmacogenetic evaluation of response to gemcitabine
in bladder cancer patients.
Phase II study of pemetrexed plus carboplatin
in malignant pleural mesothelioma.
Dramatic tumour response to pemetrexed single-agent
in an elderly patient with malignant peritoneal mesothelioma:
a case report
|